Secreted type I/III interferons diffuse into the tumor microenvironment, resulting in effective autocrine and paracrine activation of the type I/III IFN pathway and inducing significant upregulation of genes involved in antigen presentation (step 10) [106]. The gene discussed is IFNA1; the disease is neoplasm.